Price Alert

Climb Bio Inc. (CLYM)

NASDAQ: CLYM · Real-Time Price · USD

2.39

0.06 (2.58%)

At close: Sep 05, 2025, 3:59 PM

2.37

-0.84%

After-hours: Sep 05, 2025, 04:56 PM EDT

Climb Bio Statistics

Share Statistics

Climb Bio has 67.76M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	67.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	684
FTD / Avg. Volume	0.14%

Short Selling Information

The latest short interest is 1.12M, so 1.65% of the outstanding shares have been sold short.

Short Interest	1.12M
Short % of Shares Out	1.65%
Short % of Float	3.08%
Short Ratio (days to cover)	1.23

Valuation Ratios

The PE ratio is -1.17 and the forward PE ratio is -3.3. Climb Bio's PEG ratio is -0.07.

PE Ratio	-1.17
Forward PE	-3.3
PS Ratio	0
Forward PS	n/a
PB Ratio	0.41
P/FCF Ratio	-5.57
PEG Ratio	-0.07

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Climb Bio.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.41, with a Debt / Equity ratio of 0.

Current Ratio	31.41
Quick Ratio	31.41
Debt / Equity	0
Debt / EBITDA	-0.02
Debt / FCF	-0.03
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-4.35M
Employee Count	17
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is -0.1, so Climb Bio's price volatility has been lower than the market average.

Beta	-0.1
52-Week Price Change	n/a
50-Day Moving Average	1.68
200-Day Moving Average	1.7
Relative Strength Index (RSI)	63.35
Average Volume (20 Days)	502,398

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-82.02M
Net Income	-73.9M
EBITDA	-30.36M
EBIT	-30.36M
Earnings Per Share (EPS)	-1.53

Full Income Statement

Balance Sheet

The company has 87.23M in cash and 532K in debt, giving a net cash position of 86.7M.

Cash & Cash Equivalents	87.23M
Total Debt	532K
Net Cash	86.7M
Retained Earnings	-229.88M
Total Assets	192.39M
Working Capital	81.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.56M and capital expenditures 0, giving a free cash flow of -15.56M.

Operating Cash Flow	-15.56M
Capital Expenditures	n/a
Free Cash Flow	-15.56M
FCF Per Share	-0.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLYM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for CLYM is $9.5, which is 307.7% higher than the current price. The consensus rating is "Buy".

Price Target	$9.5
Price Target Difference	307.7%
Analyst Consensus	Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	11.38
Piotroski F-Score	1